US$ 22.08
glp-1 hypothyroidism and GLP-1: A Weight Loss Solution? Implications of GLP-1 Receptor Agonist
Description
One advantage liraglutide has that often gets overlooked is the depth of its safety database

Liraglutide is effective at treating both type 2 diabetes and obesity

Studies showed a remarkable effect on people with obesity: The SELECT Trial found that MACE (major adverse CVD event) risk was reduced by 20% in adults with obesity without T2D in the group taking semaglutide

of HCTU (0.4 M in DMF) and 7.5 equiv

Although, our study presents several limitations, if confirmed through dedicated randomized trial, this could further expand the role of GLP-1RAs in cardiovascular prevention
